The Relationship between the Bcl-2/Bax Ratio and Drug Resistance in Acute Myelogenous Leukemia
10.3870/j.issn.1004-0781.2001.02.007
- VernacularTitle:急性髓系白血病bcl-2与bax基因的比值和耐药
- Author:
Huiyu LI
;
Yan CHEN
;
Mingsheng HE
- Publication Type:Journal Article
- From:
Herald of Medicine
2001;(2):87-88
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate Bcl-2 and Bax gene expression in acute myelogenous Leukemia and the relationship between Bcl-2/Bax ratio and drug resistance.Method:Expression of Bcl-2、Bax was detected by immunohistochemical method while drug resistance of AML was detected by cell culture and MTT assay.Results:A high expression of Bcl-2 and a low expression of Bax were detected in AML,respectively,and the ratio between Bcl-2 and Bax was significantly higher than that in normal control (P<0.01). The ratio in those who are resistant to chemotherapy was significantly higher than that in those sensitive to chemotherapy (P<0.05).The responsiveness to chemotherapy of those with a high ratio was poorer than thos with a low ratio (P<0.05).Conclusion:The alteration of Bcl-2 and Bax played certain role in the development of drug resistance in AML,the test of Bcl-2/Bax ratio may have great significance in choice of chemotherapeutic agents and also provide important information for outcome prediction.